ICU Medical, Inc. (NASDAQ:ICUI) Stake Trimmed by Point72 Asset Management L.P.

Point72 Asset Management L.P. cut its stake in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 46.7% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 150,310 shares of the medical instruments supplier's stock after selling 131,575 shares during the quarter. Point72 Asset Management L.P. owned about 0.61% of ICU Medical worth $27,390,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of ICUI. Victory Capital Management Inc. grew its holdings in ICU Medical by 2,966.3% during the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier's stock valued at $16,844,000 after purchasing an additional 137,222 shares in the last quarter. Millennium Management LLC grew its stake in shares of ICU Medical by 327.8% during the second quarter. Millennium Management LLC now owns 136,070 shares of the medical instruments supplier's stock valued at $16,158,000 after acquiring an additional 104,264 shares in the last quarter. FMR LLC increased its position in shares of ICU Medical by 2,676.6% during the third quarter. FMR LLC now owns 104,094 shares of the medical instruments supplier's stock worth $18,968,000 after acquiring an additional 100,345 shares during the last quarter. Granite Investment Partners LLC acquired a new position in shares of ICU Medical in the second quarter worth about $10,650,000. Finally, F M Investments LLC purchased a new position in ICU Medical in the second quarter valued at about $10,175,000. Institutional investors and hedge funds own 96.10% of the company's stock.

Analyst Ratings Changes

ICUI has been the topic of several analyst reports. Raymond James lifted their price objective on ICU Medical from $158.00 to $190.00 and gave the stock an "outperform" rating in a report on Thursday, September 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. KeyCorp raised their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a report on Wednesday, November 13th. Jefferies Financial Group started coverage on shares of ICU Medical in a research report on Monday, October 14th. They issued a "hold" rating and a $183.00 target price for the company. Finally, StockNews.com raised shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Two equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, ICU Medical has an average rating of "Moderate Buy" and an average target price of $173.00.

ICU Medical Stock Performance

Shares of NASDAQ:ICUI traded up $0.09 on Friday, hitting $155.74. The company's stock had a trading volume of 163,595 shares, compared to its average volume of 272,339. ICU Medical, Inc. has a 12 month low of $83.26 and a 12 month high of $196.26. The stock's 50-day moving average is $173.16 and its two-hundred day moving average is $148.54. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The company has a market capitalization of $3.81 billion, a price-to-earnings ratio of -33.98 and a beta of 0.62.

Insiders Place Their Bets

In related news, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at $17,973,261.12. The trade was a 10.29 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, COO Christian B. Voigtlander sold 1,430 shares of the company's stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 40,364 shares of company stock worth $6,869,878. 6.70% of the stock is owned by corporate insiders.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.